Ravi Srinivasan is the founder of Onconano Medicine. Onconano Medicine has raised $12M in total funding. Latest round: Series A. Backed by Salem Partners.
Ravi Srinivasan is the Founder, President, and Chief Executive Officer of OncoNano Medicine, a company developing a new class of pH-activated compounds for disease detection and treatment, particularly in cancer. The company secured an $11.7 million Series A financing round to advance its clinical development.
Full founder directory · Investor directory · Company funding database · Fundraising library